One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Heart failure with preserved ejection fraction: innovative diagnostic approaches and therapeutic targets
Filippo Crea
doi : 10.1093/eurheartj/ehad234
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1481–1485
Make it quick and to the point: EHJ introduces new rapid communications category for faster delivery of translational data
Judith Ozkan
doi : 10.1093/eurheartj/ehad143
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1486–1487
Too hot to handle? Mitigating the effects of climate change on cardiovascular health
Judith Ozkan
doi : 10.1093/eurheartj/ehad051
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1488–1490
Obituary for Kalevi Pyörälä (1930–2023)
Guy G De Backer
doi : 10.1093/eurheartj/ehad186
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1491–1492
TRANSFORM-HF closes the loop on diuretic therapy in heart failure
Giovanna Liuzzo, Massimo Volpe
doi : 10.1093/eurheartj/ehad124
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1493–1494
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
Jukka Lehtonen, Valtteri Uusitalo, Pauli Pöyhönen, Mikko I Mäyränpää, Markku Kupari
doi : 10.1093/eurheartj/ehad067
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1495–1510
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart failure. Manifest CS, however, constitutes only the top of an iceberg as advanced imaging uncovers cardiac involvement 4 to 5 times more commonly than what is clinically detectable.
Cardiac rehabilitation for heart failure: ‘Cinderella’ or evidence-based pillar of care?
Rod S Taylor, Hasnain M Dalal, Ann-Dorthe Zwisler
doi : 10.1093/eurheartj/ehad118
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1511–1518
Cardiac rehabilitation remains the ‘Cinderella’ of treatments for heart failure. This state-of-the-art review provides a contemporary update on the evidence base, clinical guidance, and status of cardiac rehabilitation delivery for patients with heart failure.
Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
Massimiliano Lorenzini, Perry M Elliott
doi : 10.1093/eurheartj/ehad122
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1519–1521
Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
Milton Packer, Tariq Jamal Siddiqi, Javed Butler
doi : 10.1093/eurheartj/ehad158
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1522–1525
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
Chris J Kapelios, Lina Benson, Maria G Crespo-Leiro, Stefan D Anker, Andrew J S Coats, Ovidiu Chioncel, Gerasimos Filippatos, Mitja Lainscak, Theresa McDonagh, Alexandre Mebazaa, Marco Metra, Massimo F Piepoli, Giuseppe M C Rosano, Frank Ruschitzka, Gianluigi Savarese, Petar M Seferovic, Maurizio Volterrani, Aldo P Maggioni, Lars H Lund
doi : 10.1093/eurheartj/ehad109
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1526–1529
Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India
Gnanaraj Justin Paul, Steaphen Anne Princy, Surendran Anju, Susikar Anita, Majella Cecily Mary, Ganesan Gnanavelu, Kandasamy Kanmani, Mahalingam Meena, Mohanan Nandakumaran, Swaminathan Ramya, Govindarajulu Ravishankar, Gunasingh Shaanthi, Somasundaram Shoba, Venkatesan Sangareddi, Subramanian Vijaya, the M-PAC investigators
doi : 10.1093/eurheartj/ehad003
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1530–1540
To evaluate the feto-maternal outcome, identify the adverse outcome predictors and test the applicability of modified WHO (mWHO) classification in pregnant women with heart disease (PWWHD) from Tamil Nadu, India.
Pregnancy outcomes in women with heart disease: how to improve?
Jolien W Roos-Hesselink, Johanna A van der Zande, Mark R Johnson
doi : 10.1093/eurheartj/ehad035
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1541–1543
Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea clinic
Jan Verwerft, Lucie Soens, Jokke Wynants, Marc Meysman, Siddharth Jogani, Danielle Plein, Sarah Stroobants, Lieven Herbots, Frederik H Verbrugge
doi : 10.1093/eurheartj/ehad141
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1544–1556
Heart failure with preserved ejection fraction (HFpEF) is a syndrome with a heterogeneous presentation. This study provides an in-;depth description of haemodynamic and metabolic alterations revealed by systematic assessment through cardiopulmonary exercise testing combined with exercise echocardiography (CPETecho) within a dedicated dyspnoea clinic.
Do we need dedicated heart failure with preserved ejection fraction clinics?
Carolyn S P Lam, Jennifer E Ho
doi : 10.1093/eurheartj/ehad172
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1557–1559
Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy
Marco Luciani, Mauro Montalbano, Luca Troncone, Camilla Bacchin, Keita Uchida, Gianlorenzo Daniele, Bethany Jacobs Wolf, Helen M Butler, Justin Kiel, Stefano Berto, Cortney Gensemer, Kelsey Moore, Jordan Morningstar, Thamonwan Diteepeng, Onder Albayram, José F Abisambra, Russell A Norris, Thomas G Di Salvo, Benjamin Prosser, Rakez Kayed, Federica del Monte
doi : 10.1093/eurheartj/ehad205
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1560–1570
Amyloid plaques and neurofibrillary tangles, the molecular lesions that characterize Alzheimer’s disease (AD) and other forms of dementia, are emerging as determinants of proteinopathies ‘beyond the brain’. This study aims to establish tau’s putative pathophysiological mechanistic roles and potential future therapeutic targeting of tau in heart failure (HF).
Big tau aggregation and the broken heart
Obed O Nyarko, Carmen C Sucharov
doi : 10.1093/eurheartj/ehad204
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1571–1573
The TANSNIP-PESA trial is not the end of the story
Ulf Näslund, Margareta Norberg, Patrik Wennberg
doi : 10.1093/eurheartj/ehad135
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Page 1574
Motivational interview and imaging of subclinical atherosclerosis for cardiovascular disease prevention: a winning combination?
Ines Garcia-Lunar, Borja Ibanez, Valentin Fuster
doi : 10.1093/eurheartj/ehad126
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1575–1576
Simultaneous percutaneous closure of aortic paravalvular leak and residual shunt of ventricular septal defect
Yu Han, Zirui Sun, Taibing Fan
doi : 10.1093/eurheartj/ehac804
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Page 1577
Successful management of aortic root thrombosis in a patient with Heartmate 3
So-Young Lee, Suyon Chang, Jong-Chan Youn
doi : 10.1093/eurheartj/ehad111
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Page 1578
